Research and Development

With the weekend on the horizon and a new issue of Pharmafocus hitting press, we review the most read, shared …

Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient …

A new study has emerged that reveals another clue into the process of ageing and how, on a cellular level, …

DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …

GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …

A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …

GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …

Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …

Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …

The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …